Thomas Hille
63Patents
12h-index
69Co-inventors
87Inventor score
Filing activity: Dec 18, 1989 → Apr 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5240711A | Transdermal therapeutic system comprising as active component buprenorphine | Human Necessities | 112 | Expired |
| US6059913A | Method for producing transdermal patches (TTS) | Emerging Cross-Sectional Technologies | 73 | Expired |
| US5700480A | Transdermal therapeutic system comprising galanthamine as active component | Human Necessities | 69 | Expired |
| US6344211B1 | Transdermal absorption of active substances from subcooled melts | Human Necessities | 64 | Expired |
| US7384651B2 | Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience | Human Necessities | 31 | Expired |
| US6814976B1 | Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience | Human Necessities | 30 | Expired |
| US6264980A | Transdermal resorption of active substances from supercooled masses of levulic acid | Human Necessities | 29 | Expired |
| US5391375A | Transdermal therapeutical system with physostigmine as active component and process for the production thereof | Human Necessities | 20 | Expired |
| US5089267A | Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof | Human Necessities | 20 | Expired |
| US5895660A | Deuterated active substances in transdermal application | Human Necessities | 16 | Expired |
| US9308202B2 | Transdermal therapeutic system for administering the active substance buprenorphine | Human Necessities | 14 | Active |
| US6187322A | Process and a device for the production of a flat administration form comprising a preparation which contains pharmaceutical active substances | Human Necessities | 12 | Expired |
| US7115701B2 | Method for the continuous production of high-molecular polyester and device for carrying out the method | Performing Operations; Transporting | 11 | Expired |
| US6315854A | Transdermal therapeutic plaster | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9549903B2 | Transdermal delivery system comprising buprenorphine | Human Necessities | 10 | Active |
| US6548510B1 | Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence | Human Necessities | 9 | Expired |
| US7824707B2 | Transdermal therapeutic system provided with improved long-term carrying comfort | Human Necessities | 9 | Expired |
| US5891290A | Method for the transfer of sections that are self-adhesive on one side from a moving first web onto a moving second web | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5681413A | Production of transdermal therapeutic systems | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5877172A | Process for isolating galanthamine | Human Necessities | 6 | Expired |
| US6868286B1 | Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application | Human Necessities | 6 | Expired |
| US9089527B2 | Transdermal therapeutic system comprising ion pair microreservoirs | Human Necessities | 6 | Active |
| US6194404A | Process for the isolation of galanthamine | Human Necessities | 5 | Expired |
| US6114347A | Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors | Human Necessities | 5 | Expired |
| US7259227B2 | Method for continuous production of high-molecular weight polyesters and device for implementation of the method | Performing Operations; Transporting | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.